Central Middlesex Hospital

Central Middlesex hospital is in the centre of the Park Royal business estate, on the border of two London boroughs, Brent and Ealing. Hospital roleCMH is a teaching hospital of Imperial College School of Medicine and part of the London North West Healthcare NHS Trust. This trust incorporates Northwick Park and St Mark's Hospitals in Harrow, Central Middlesex Hospital in Park Royal and outreach services based close to the local communities in Wembley, Willesden, Stanmore and Harlesden. There are 214 beds on site in general medicine, general surgery, urology including orthopaedics, ENT, ophthalmology, oral surgery, obstetrics, gynaecology, cardiology and gastroenterology. The hospital has particular experience in the care of patients with conditions aggravated by deprivation, specifically TB, diabetes and coronary heart disease, and is a leader in the research and treatment of sickle-cell disease. CMH has recently been rebuilt, using the proceeds of land sales and a PFI project. The old buildings were demolished, to be replaced by modern and accessible new ones, including the ACAD Centre (1999) and main building (2006). Much of the original site has been sold for complementary mixed-use redevelopment, including residential accommodation.

Central Middlesex hospital is in the centre of the Park Royal business estate, on the border of two London boroughs, Brent and Ealing. Hospital roleCMH is a teaching hospital of Imperial College School of Medicine and part of the London North West Healthcare NHS Trust. This trust incorporates Northwick Park and St Mark's Hospitals in Harrow, Central Middlesex Hospital in Park Royal and outreach services based close to the local communities in Wembley, Willesden, Stanmore and Harlesden. There are 214 beds on site in general medicine, general surgery, urology including orthopaedics, ENT, ophthalmology, oral surgery, obstetrics, gynaecology, cardiology and gastroenterology. The hospital has particular experience in the care of patients with conditions aggravated by deprivation, specifically TB, diabetes and coronary heart disease, and is a leader in the research and treatment of sickle-cell disease. CMH has recently been rebuilt, using the proceeds of land sales and a PFI project. The old buildings were demolished, to be replaced by modern and accessible new ones, including the ACAD Centre (1999) and main building (2006). Much of the original site has been sold for complementary mixed-use redevelopment, including residential accommodation.